secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvus Pharmaceuticals, Inc. (CRVS)
CIK:        0001626971
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001171843-24-003444
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Corvus shareholders elect Scott Morrison to board, ratify PwC, approve exec pay
-------------------------------------------------------------------------------

- Scott W. Morrison elected Class II director with 19,667,286 votes for, 5,398,946 withheld.
- Ratification of PricewaterhouseCoopers as independent auditor for FY 2024: 35,776,658 for, 65,997 against.
- Non-binding advisory vote to approve named executive officer compensation passed: 24,424,413 for, 413,670 against.
- Record date April 18, 2024; 49,038,582 shares outstanding, 35,968,782 voted at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626971/000117184324003444/0001171843-24-003444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626971/000117184324003444/f8k_061424.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-003444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer